Fulcrum Therapeutics, Inc. Stock Forecast
Strong day for Fulcrum Therapeutics, Inc. stock price on Monday rising 5.99% to $7.25
(Updated on Apr 22, 2024)
The Fulcrum Therapeutics, Inc. stock price gained 5.99% on the last trading day (Monday, 22nd Apr 2024), rising from $6.84 to $7.25. During the last trading day the stock fluctuated 5.99% from a day low at $6.85 to a day high of $7.26. The price has fallen in 7 of the last 10 days and is down by -14.2% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 35 thousand more shares were traded than the day before. In total, 583 thousand shares were bought and sold for approximately $4.23 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.53% during the next 3 months and, with a 90% probability hold a price between $7.02 and $12.46 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
FULC Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 5.99%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fulcrum Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $9.37. On a fall, the stock will find some support from the short-term average at $7.22. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Fulcrum Therapeutics, Inc. stock
Fulcrum Therapeutics, Inc. finds support from accumulated volume at $7.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.410 between high and low, or 5.99%. For the last week, the stock has had daily average volatility of 5.84%.
Fulcrum Therapeutics, Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: $6.91 (-4.64%) (This stock has high daily movements and this gives high risk. Low RSI14 is 18 which reduces the risk some. There is a buy signal from a pivot bottom found 1 day ago.)
Trading Expectations (FULC) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Fulcrum Therapeutics, Inc. to open at $7.12, and during the day (based on 14 day Average True Range), to move between $6.70 and $7.80, which gives a possible trading interval of +/-$0.550 (+/-7.58%) up or down from last closing price. If Fulcrum Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 15.16% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $7.00 (3.45%) than the resistance at $7.75 (6.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Fulcrum Therapeutics, Inc. stock A Buy?
Fulcrum Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.376 Hold/Accumulate Upgraded
Predicted Opening Price for Fulcrum Therapeutics, Inc. of Tuesday, April 23, 2024
| Fair opening price April 23, 2024 | Current price |
|---|---|
| $7.12 ( 1.79%) | $7.25 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for FULC
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 7.53 | 3.86 % | |
| R2 | 7.37 | 1.70 % | ||
| R1 | 7.28 | 0.367 % | ||
| Current price: | 7.25 | |||
| Support | S1 | 6.96 | -3.95 % | |
| S2 | 6.87 | -5.29 % | ||
| S3 | 6.71 | -7.45 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 8.95 | 23.45 % | |
| R2 | 8.45 | 16.55 % | ||
| R1 | 7.75 | 6.90 % | ||
| Current price | 7.25 | |||
| Support | S1 | 7.00 | -3.45% | |
| S2 | 6.84 | -5.66% | ||
| S3 | 6.72 | -7.31% |
FAQ
Click here for our free guide on how to buy Fulcrum Therapeutics, Inc. Stock.
